A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
מצבים רפואיים
Epidermal Growth Factor · Epidermal Growth Factor Receptor · Epidermal Growth Factor Receptor Gene Mutation · Non Small Cell · Non Small Cell Lung · Non Small Cell Lung Cancer · Head and Neck · Head and Neck Cancer · Head and Neck Cancers · Head and Neck Squamous Cell Cancer · Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma HNSCC · NSCLC (Non-small Cell Lung Cancer) · HNSCC · EGFR
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
START Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startreseach.com · 650-955-7486Astera Cancer Care, East Brunswick, New Jersey, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startresearch.com · 650-955-7486START New York Long Island, Lake Success, New York, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startresearch.com · 650-955-7486Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · clinicaltrials@epibiologics.com · 650-955-7486MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · clinicaltrials@epibiologics.com · 650-955-7486South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startreseach.com · 650-955-7486